Remedent, Inc. Announces First Marketing and Distribution Agreement Introducing Glamsmile(TM) Veneers into Asian Market

  
    
  
  
    
      Remedent, Inc. (OTCBB: REMI), an international company specializing in 
      the research, development, manufacturing of oral care and cosmetic 
      dentistry products, today announced that it has signed an exclusive 
      agreement with Accendo Healthcare Pte Ltd., a leading OTC distributor of 
      healthcare products in Singapore, for the marketing and distribution of 
      Glamsmile™, a revolutionary cosmetic dental 
      system that substantially expands the consumer and professional dental 
      market for veneers.
    
    
      Accendo agreed to a negotiated upfront payment and, in order to maintain 
      its exclusivity in the Singapore market, Accendo further agreed to 
      purchase and install a specified minimum number of Glamsmile™ 
      veneers annually. Both the upfront payment and the minimum number of 
      Glamsmile™ installations were related to the 
      size of the Singapore market opportunity.
    
    
      Mr. Guy De Vreese, Chairman of Remedent, noted, “Our 
      agreement with Accendo Healthcare, a longtime partner of Remedent in 
      introducing new innovative dental products into Singapore, is 
      significant in that it marks the first step by Remedent to expand 
      acceptance of its Glamsmile™ veneers into the 
      Asian market, a very large and relatively untapped opportunity. We 
      anticipate agreements with other Asian countries will quickly follow; a 
      number of which are substantially larger than Singapore and could, 
      therefore, require both larger upfront payments and higher minimum 
      yearly Glamsmile™ installations to maintain 
      exclusivity.”
    
    
      About Remedent, Inc.
    
    
      Remedent, Inc., a publicly-traded company on the OTCBB, 
      specializes in the research, development, manufacturing and marketing of 
      oral care and cosmetic dentistry products. With offices in California, 
      Belgium and Singapore, Remedent distributes its products in more than 35 
      countries. For additional information, visit Remedent's web site at www.remedent.com.
    
    
      FORWARD-LOOKING STATEMENTS
    
    
      “Safe Harbor” 
      Statement under the Private Securities Litigation Reform Act of 1995: 
      The statements by Guy De Vreese, the statements regarding growth of the 
      GlamsmileTM product line, optimism related to 
      the business, expanding sales, the Asian market and other statements in 
      this press release are forward-looking statements within the meaning of 
      the Securities Litigation Reform Act of 1995. Such statements are based 
      on current expectations, estimates and projections about the Company’s 
      business. Words such as expects, anticipates, intends, plans, believes, 
      sees, estimates and variations of such words and similar expressions are 
      intended to identify such forward-looking statements. These statements 
      are not guarantees of future performance and involve certain risks and 
      uncertainties that are difficult to predict. Actual results could vary 
      materially from the description contained herein due to many factors 
      including continued market acceptance of the Company’s 
      products. In addition, actual results could vary materially based on 
      changes or slower growth in the oral care and cosmetic dentistry 
      products market; the potential inability to realize expected benefits 
      and synergies; domestic and international business and economic 
      conditions; changes in the dental industry; unexpected difficulties in 
      penetrating the oral care and cosmetic dentistry products market; 
      changes in customer demand or ordering patterns; changes in the 
      competitive environment including pricing pressures or technological 
      changes; technological advances; shortages of manufacturing capacity; 
      future production variables impacting excess inventory and other risk 
      factors listed from time to time in the Company’s 
      Securities and Exchange Commission filings under “risk 
      factors” and elsewhere. The forward-looking 
      statements contained in this press release speak only as of the date on 
      which they are made, and the Company does not undertake any obligation 
      to update any forward-looking statement to reflect events or 
      circumstances after the date of this press release.